A national guidance has been published on the website van the FAMHP:
https://www.fagg.be/nl/news/coronavirus_belgische_richtsnoer_voor_het_beheer_van_klinische_proeven_tijdens_de

This national  guidance is to be read together with the latest version of the European guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic:
https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf.

The document is the result of a collaboration between the FAMHP, the CT-College, BAREC and some clinical trial sites.

It is complementary to the European guidance and provides additional directions to clinical trial sponsors in the management of Belgian

(i) clinical trials for treatment or prevention of COVID-19, and
(ii) ongoing clinical trials.

This national guideline will be regularly adapted to the evolution of the pandemic.